LifeStance Health Group (LFST) director withholds shares for RSU taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
LifeStance Health Group director Kenneth A. Burdick reported a tax-related share withholding tied to vested restricted stock units. On March 6, 2026, the issuer withheld 424,551 shares of common stock at $7.11 per share to cover tax obligations, which the filing states is not an open-market sale. After this net settlement, Burdick directly holds 3,012,020 shares and indirectly holds 46,511 shares through Burdick Family LLC.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Burdick Kenneth A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 424,551 | $7.11 | $3.02M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 3,012,020 shares (Direct);
Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did LifeStance (LFST) report for Kenneth A. Burdick?
Kenneth A. Burdick reported a tax-related share withholding. On March 6, 2026, 424,551 LifeStance common shares were withheld to satisfy tax obligations from vested RSUs, which the filing clarifies did not involve any open-market sale of shares.
Was Kenneth Burdick’s LifeStance (LFST) Form 4 an open-market stock sale?
No, the Form 4 does not report an open-market sale. The filing explains that 424,551 shares were withheld by the issuer solely to satisfy tax withholding obligations on vested RSUs, rather than sold in the open market.
What indirect LifeStance (LFST) holdings does Kenneth Burdick report?
Burdick reports 46,511 LifeStance shares as indirect holdings. These shares are held through Burdick Family LLC, with the Form 4 designating this position as indirect ownership separate from his directly held common stock.